Clinical Investigation of Fasudil for the Prevention of Cerebral Vasospasm in Extracranial Carotid Artery Stenting
暂无分享,去创建一个
[1] Paul Vespa,et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2012, Stroke.
[2] E. Keller,et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought , 2009, Neurological research.
[3] C. Schirmer,et al. Iatrogenic vasospasm in carotid artery stent angioplasty with distal protection devices. , 2008, Neurosurgical focus.
[4] E. Peterson,et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). , 2007, Journal of the American College of Cardiology.
[5] E. Peterson,et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on carotid stenting. , 2007, Vascular medicine.
[6] P. Ganz,et al. Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery Disease , 2006, Circulation research.
[7] V. Feigin,et al. Calcium Antagonists in Aneurysmal Subarachnoid Hemorrhage , 2005, The Cochrane database of systematic reviews.
[8] Thomas Jahnke,et al. Vessel wall damage caused by cerebral protection devices: ex vivo evaluation in porcine carotid arteries. , 2005, Radiology.
[9] P. Meyers,et al. Treatment of mechanically-induced vasospasm of the carotid artery in a primate using intra-arterial verapamil: a technical case report , 2004, BMC cardiovascular disorders.
[10] E. A. Stevens,et al. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. , 2004, Journal of Neurosurgery.
[11] A. Takeshita,et al. Rho/Rho-Kinase Pathway in the Brainstem Contributes to Hypertension Caused by Chronic Nitric Oxide Synthase Inhibition , 2004, Hypertension.
[12] F. Setacci,et al. Protected Carotid Stenting: Clinical Advantages and Complications of Embolic Protection Devices in 442 Consecutive Patients , 2003, Stroke.
[13] 中島 正明. Effects of Aging on Cerebral Vasospasm After Subarachnoid Hemorrhage in Rabbits , 2001 .
[14] I. Date,et al. Effects of Aging on Cerebral Vasospasm After Subarachnoid Hemorrhage in Rabbits , 2001, Stroke.
[15] J. Findlay. Current Management of Aneurysmal Subarachnoid Hemorrhage Guidelines from the Canadian Neurosurgical Society , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[16] Findlay Jm. Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society. , 1997 .
[17] R. Macdonald,et al. Papaverine-sensitive vasospasm and arterial contractility and compliance after subarachnoid hemorrhage in dogs. , 1995, Neurosurgery.
[18] T. Huber. Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis , 2011 .
[19] M. Shibuya,et al. Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. , 2001, Acta neurochirurgica. Supplement.
[20] W. Thies,et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.